How does the SSM affect member spending on medications?

The correct choice highlights how the SSM, or Smart Spend Model, specifically aims to make medications, particularly insulin, more affordable for members. This model addresses the financial barriers often faced by individuals requiring insulin for diabetes management.

By implementing strategies that encourage the use of cost-effective options, the SSM effectively lowers out-of-pocket expenses for insulin. This can involve negotiating better prices with pharmaceutical manufacturers or promoting generics and biosimilars that provide similar efficacy at a reduced cost. Consequently, members can access necessary medications without facing overwhelming financial burdens, which is crucial for maintaining their health and preventing complications associated with diabetes.

Other choices may imply impacts that do not accurately reflect the goals of the SSM. For instance, increasing spending or eliminating spending do not align with the primary objective of helping members manage their medication costs. Limiting pharmacy choices could suggest a restriction that goes against the SSM's intent to enhance affordability and accessibility for members.